Showing results (281-290 of 1,274) with videos related to

Sort By:
Pageof 128
Clinical Colorectal Cancer|August 22, 2024
Adaptive Immune Receptor Distinctions Along the Colorectal Polyp-Tumor TimelapseTaha I Huda, Diep Nguyen, Arpan Sahoo, et al.
Clinical Colorectal Cancer|October 23, 2024
A National Cancer Database Analysis of the Characteristics and Outcome of Colon Cancer According to Type of Preexisting AdenomaSameh Hany Emile, Nir Horesh, Victor Strassmann, et al.
Clinical Colorectal Cancer|September 28, 2024
Different Metabolic Associations of Hepatitis C With Colon and Rectal Cancers: A 9-Year Nationwide Population-Based Cohort StudyChun-Wei Chen, Jur- Shan Cheng, Tsung-Hsing Chen, et al.
Clinical Colorectal Cancer|April 9, 2025
Circulating Tumor DNA in Addition to Fecal Immunochemical Test in a Dual-Test Colorectal Cancer Screening ApproachCaroline L Kahn, Mathias M Petersen, Jakob Kleif, et al.
Clinical Colorectal Cancer|March 19, 2025
A Phase Two, Single-Arm, Open-Label Study With Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)Andrea Cercek, Jean-Baptiste Bachet, Jaume Capdevila, et al.
Clinical Colorectal Cancer|March 23, 2025
Number of Lymph Nodes Examined as a Prognosis Factor in Patients With Stage II or III Colon CancerHyunwook Kim, Lingjie Shen, Jeongseok Jeon, et al.
Clinical Colorectal Cancer|February 28, 2025
Association Between Colorectal Cancer Primary Features and Liver Metastases Histological Growth Patterns: Inflammation on the Primary Tumor is Associated with Desmoplastic Growth PatternAna Margarida Abrantes, Rui Caetano-Oliveira, Bárbara Oliveiros, et al.
Clinical Colorectal Cancer|June 28, 2024
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal CancerAlberto Bessudo, Abdul Mustajeeb Haseeb, James A Reeves, et al.
Clinical Colorectal Cancer|June 7, 2024
VIC Regimen (Vemurafenib/Irinotecan/Cetuximab) Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Unresectable or Metastatic Colorectal Cancer in Asian Patients: A Prospective Cohort StudyYijiao Chen, Dexiang Zhu, Yiyi Yu, et al.
Clinical Colorectal Cancer|May 24, 2024
Potential for Metastasis and Recurrence in Colorectal Carcinoma In Situ: A Retrospective Analysis of 1069 PatientsSeijong Kim, Jung Kyong Shin, Yoonah Park, et al.
Pageof 128